Henan Newland Pharmaceutical Co. Ltd. A Net Asset Quality Index
Henan Newland Pharmaceutical Co. Ltd. A net asset quality index. Henan Newland Pharmaceutical Co. Ltd. A (301277) has a Net Asset Quality Index of 87.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥1.82 Billion minus total liabilities of CN¥236.14 Million yields net assets of CN¥1.59 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Henan Newland Pharmaceutical Co. Ltd. A net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Henan Newland Pharmaceutical Co. Ltd. A (2020–2025)
Net asset quality index of Henan Newland Pharmaceutical Co. Ltd. A from 2020 to 2025. This chart shows how Henan Newland Pharmaceutical Co. Ltd. A's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 87.0%, representing net assets of CN¥1.59 Billion against total assets of CN¥1.82 Billion CNY. Check 301277 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Henan Newland Pharmaceutical Co. Ltd. A Net Asset Quality Index by Year (2020–2025)
Henan Newland Pharmaceutical Co. Ltd. A net asset quality index by year from 2020 to 2025. The table below presents the year-by-year Net Asset Quality Index for Henan Newland Pharmaceutical Co. Ltd. A from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Henan Newland Pharmaceutical Co. Ltd. A stock valuation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 87.2% | CN¥1.55 Billion | CN¥1.78 Billion | CN¥228.49 Million | ▲ +2.1 pp |
| 2024 | 85.1% | CN¥1.54 Billion | CN¥1.81 Billion | CN¥270.69 Million | ▼ -5.0 pp |
| 2023 | 90.1% | CN¥1.45 Billion | CN¥1.61 Billion | CN¥160.02 Million | ▲ +1.4 pp |
| 2022 | 88.6% | CN¥1.36 Billion | CN¥1.53 Billion | CN¥174.58 Million | ▲ +27.8 pp |
| 2021 | 60.8% | CN¥406.38 Million | CN¥667.90 Million | CN¥261.53 Million | ▲ +0.8 pp |
| 2020 | 60.0% | CN¥313.39 Million | CN¥521.96 Million | CN¥208.57 Million | — |